Persistent left superior vena cava connecting to the roof of left-sided atrium

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

1 event
May 1987

Pentaspan: FDA approved

As an adjunct in leukapheresis to improve the harvesting and increase the yield of leukocytes by centrifugal means.

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

1

Copay cards

Copay Assistance1

Pentaspan

DuPont Pharmaceuticals

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Pentaspan

(Pentastarch)Orphan drug

DuPont Pharmaceuticals

Approved May 1987

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Persistent left superior vena cava connecting to the roof of left-sided atrium.
Search all trials →
Search clinical trials for Persistent left superior vena cava connecting to the roof of left-sided atrium

Recent News & Research

No recent news articles indexed yet for Persistent left superior vena cava connecting to the roof of left-sided atrium.
Search PubMed for Persistent left superior vena cava connecting to the roof of left-sided atrium

Browse all Persistent left superior vena cava connecting to the roof of left-sided atrium news →

Specialist Network

No specialists currently listed for Persistent left superior vena cava connecting to the roof of left-sided atrium.

View all Persistent left superior vena cava connecting to the roof of left-sided atrium specialists →

Quick Actions